REVERSAL AGENTS FOR NOACS: Do WE NEED THEM in THE EP LAB?

ESC Guidelines: Anticoagulation Use in AF

Checklist for Anticoagulation Prior to Ablation Procedure

Idarucizumab Is Now Approved

Idarucizumab Has Demonstrated Fast and Reliable Reversal of Dabigatran as Measured by dTT Levels

EHRA Scientific Statement: What Is the Recommended Periprocedural NOAC Use During AF Ablation?

Research Continues…Uninterrupted Use of NOACs During Ablation

Management of Bleeding in the EP Lab

Management of Cardiac Tamponade During Ablation for AF: Leipzig Heart Institute

Restarting the NOAC After a Bleeding Event Following Ablation

ESC Guidelines for AF: Cardioversion, TEE, and Anticoagulation

Conclusions

Conclusions (cont)

Abbreviations

Abbreviations (cont)